To obtain access to any datasets listed on this site, you must first receive approval from NIDA Datashare's Data Access Committee (DAC).

Please submit your request by sending your request to NIDA_Datashare_DAC@mail.nih.gov along with the following information:

  • Your name, title, and organization
  • Study Number and Study Title
  • The specific dataset(s) you are requesting
  • The intended use or purpose of the data
  • Willingness to comply with the NIDA Datashare Registration Agreement
Once your request is reviewed, you will receive instructions on how to proceed.

Thank you for your cooperation.

NIDA-CTN-0013

Division
HEAL Study
Investigator(s)
Title
Motivational Enhancement Therapy (MET) to Improve Treatment Utilization and Outcome in Pregnant Substance Users
Short Description
This study compares Motivational Enhancement Therapy (MET)with standard treatment in both alcohol and drug-using women.
Release Date
May 27, 2008
Description

About 5% of women use illicit substances during pregnancy, and approximately 22% of these also report using tobacco or alcohol. A number of treatment programs have started to offer treatment specifically designed for pregnant substance abusers. While these programs have shown some success, it is still difficult to keep these women in treatment. Brief motivational sessions have been found to improve treatment engagement and outcomes in both alcohol and drug using women. This study compares one such treatment intervention, Motivational Enhancement Therapy (MET), with standard treatment. The three individual MET sessions focus on developing rapport, exploring perceived pros and cons of using substances, reviewing the participant’s feedback on the consequences of substance use and the status of her pregnancy, and developing a change plan or strengthening the commitment to change. Patients assigned to standard treatment receive the treatment normally given in that clinic; this will include at least three individual sessions that are also designed to help them overcome alcohol and drug use.

Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Links